The effects of replacing β-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients

American Journal of Hypertension

Volumn 9, Issue 12 I, 1996, Pages 1206-1213

  Paran, Esther ^a,b   Anson, Ofra ^a   Neumann, Lily ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

blocker; angiotensin converting enzyme inhibitors; atenolol; captopril; hypertension; propranolol; quality of life

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; PROPRANOLOL;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATENOLOL; BLOOD PRESSURE; CAPTOPRIL; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; PROPRANOLOL; QUALITY OF LIFE; QUESTIONNAIRES; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 0030446392     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(96)00253-1     Document Type: Article

References (29)

1. Fowlie M, Berkeley J: Quality of life - a review of the literature. Family Practice 1987;4:226-234.
2. Moinpour CM, Feigl P, Match B, et al: Quality of life end points in cancer clinical trials: review and recommendations. J Natl Cancer Inst 1989;8a:485-495.
3. Wachtel T, Piette J, Mor V, et al: Quality of life in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study instrument. Ann Intern Med 1992;116:166-167.
4. Bombardier C, Ware J, Russell IJ, et al: Auranofin therapy and quality of life in patients with rheumatoid arthritis: results of a multicenter trial. Am J Med 1986; 81:565-578.
5. Tandon RK, Stander H, Schwarz RP, Jr: Analysis of quality of life data from a randomized, placebo-controlled heart-failure trail. J Clin Epidemiol 1989;42:955-962.
6. Croog SH, Levine S, Testa MA, et al: The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986;314:1657-1664.
7. Beto JA, Bansal VK: Quality of life in treatment of hypertension: a metaanalysis of clinical trails. J Hypertens 1992;5:125-133.
8. Davis AR, Ware JE: Measuring Health Perceptions in the Health Insurance Experiment. Rand, Santa Monica, CA, 1981.
9. Linder-Pelz S, Levy S, Tamir A, et al: A measure of family functioning for health care practice and research in Israel. Comp Family Stud 1984;XV:211-229.
10. Kozma A, Stones MJ: The measurement of happiness: Development of the Memorial University of Newfoundland Scale of happiness (MUNSH). J Gerontol 1980;35:906-912.
11. Viet CT, Ware JE: The structure of psychological distress and well-being in general populations. J Consult Clin Psychol 1983;14:74-81.
12. Antonovsky A: Health, Stress and Coping: New Perspectives on Mental and Physical Well-Being. Jossey-Bass, San Francisco, 1979.
13. Antonovsky A: Unraveling the Mystery of Health. Jossey-Bass, San Francisco, 1987.
14. Donald CA, Ware JE: The Quantification of Social Contacts and Resources. Rand, Santa Monica, CA, 1982.
15. Fletcher AE, Bulpitt CJ: The effects of verapamil and propranolol on quality of life in hypertension. J Hum Hypertens 1989;3:125-130.
16. Palmer A, Fletcher A, Hamilton G, et al: A comparison of verapamil and nifedipine on quality of life. Br J Clin Pharmacol 1990;30:365-370.
17. Schoenberger JA, Testa M, Ross AD, et al: Efficacy, safety, and quality-of-life assessment of catopril antihypertensive therapy in clinical practice. Arch Intern Med 1990;150:301-306.
18. Williams GH: Quality of life and its impact on hypertensive patients. Am J Med 1987;82:98-105.
19. Johnston ME, Gibson ES, Terry CW et al: Effects of labeling on income, work, and social function among hypertensive employees. J Chronic Dis 1984;37:417-423.
20. Fletcher AE, Bulpitt CJ, Hawkins CM, et al: Quality of life on antihypertensive therapy: a randomized double-blind controlled trail of captopril and atenolol. J Hypertens 1990;8:463-466.
21. Wenger NK: Quality of life issues in hypertension: Consequences of diagnosis and considerations in management. Am Heart J 1988;116:628-631.
22. Williams GH, Croog SH, Levine S, et al: Impact of antihypertensive therapy on quality of life: effect of hydrochlorothiazide. J Hypertens 1987;5:S29-S35.
23. Testa MA, Anderson RB, Nackley JF, Hollenberg NK: The Quality-of-Life Hypertension Study Group. Quality of life and antihypertensive therapy in men: a comparison of captopril with enalapril. N Engl J Med 1993; 328:907-913.
24. Rosenthal T, Algom M, Chaynas A, et al: Captopril as a replacement therapy in hypertension improving quality of life (a multicenter study). Postgrad Med J 1986;62:114-116.
25. Jern S, Hansson L, Schersten B, et al: Swedish isradipine study in hypertension: evaluation of quality of life, safety, and efficacy. J Cardiovasc Pharmacol 1991; 18:S7,S8.
26. Weir MR, Josselson J, Ekelund LG, et al: Nicardipine as antihypertensive monotherapy: positive effects on quality of life. J Hum Hypertens 1991;5:205-213.
27. Fagher B, Katzman P, Hulthen UL, et al: Antihypertensive efficacy and tolerability of enalapril and slow-release verapamil in essential hypertension: a double-blind crossover study. J Intern Med 1991;230:219-226.
28. Navarro RP, O'Brien DK, Nuffort P, Spencer DL: Diuretic induced hypokalemia in the elderly. J Fam Pract 1982;14:685-688.
29. Paran E, Anson O, Neumann L: The effect of diuretics on quality of life of hypertensive patients. J Hum Hypertens 1996;10:S147-S152.